問題一覧
1
DDB
2
Ponstan 500 mg
3
Increased risk of GI bleeding
4
Ginseng - Amitriptyline
5
Contrast media
6
Phenylephrine
7
It blocks H1-receptors in the brain
8
N-acetylcysteine
9
Bone marrow suppression
10
I only
11
Omeprazole beads in applesauce for Edna with GERD and has problems swallowing capsules
12
Sirolimus
13
Vasopressin
14
M. ft. sol
15
If another drop of eye medication is needed, immediately instill another drop in the same area
16
Aged cheese, Moclobemide
17
Benign Prostatic Hypertrophy (BPH)
18
Atorvastatin
19
II only
20
III,IV
21
Synergism
22
II, IV
23
Type E
24
Type C: Cardiotoxicity by Doxorubicin
25
Signa
26
Precaution, Warning, Contraindication
27
Object drug
28
III and V
29
All except II and IV
30
I and III
31
No effect on the antibiotic with decreased effect of the OCP
32
I and II only
33
Category C
34
Category D
35
III and IV only
36
Pharmaceutical alternative
37
DOPamine and DOBUTamine
38
Patients must be discouraged from drinking alcohol while on metronidazole therapy
39
Leaching
40
Category H
41
I, IV, and V
42
Aspirin
43
Alkalinize the urine
44
Decrease in the absorption of the fat-soluble vitamins
45
An antimetabolite
46
S3
47
Both
48
I and III
49
Has a longer half-life
50
Hyperkalemia
51
Stage 1 hypertension
52
Prolonged muscle spasms
53
Kwashiorkor
54
Piperacillin and tazobactam exhibit pharmacodynamic potentiation
55
Increased serum concentration of Lipitor
56
Pioglitazone
57
Hypomagnesemia
58
Irreversible inactivation of H+/K+ ATPase
59
II, IV
60
Potassium
61
Vitamin B12
62
Cost Benefit Analysis
63
Cost-Utility Analysis
64
Not True
65
Category E
66
Liver function test
67
Average weight of hemoglobin contained in a red cell
68
Sildenafil
69
K Sparing Diuretic
70
Custodial Care Facility
71
Primary Care Facility
72
All except III
73
III, IV, V
74
Level 3
75
Core List
76
18
77
Troponin I
78
Administration of narcotic analgesic
79
Violative
80
III, II, V, IV, I
81
0.75
82
500
83
1.33
84
15,000
85
136.36
86
0.6
87
88.68
88
0.812 g/mL
89
3.61%
90
0.50
91
33.90%v/v
92
11.08 mL/hr
93
6 pm
94
Overdose
95
45.75 mg
96
20 mg
97
470 mg
98
2.93
99
75.26
100
3000 mOsmol/L
Module 2 Part 1
Module 2 Part 1
ユーザ名非公開 · 100問 · 1年前Module 2 Part 1
Module 2 Part 1
100問 • 1年前Module 1
Module 1
ユーザ名非公開 · 13問 · 1年前Module 1
Module 1
13問 • 1年前Module 2
Module 2
ユーザ名非公開 · 100問 · 1年前Module 2
Module 2
100問 • 1年前Antibiotics
Antibiotics
ユーザ名非公開 · 10問 · 1年前Antibiotics
Antibiotics
10問 • 1年前Module 2 Part 2
Module 2 Part 2
ユーザ名非公開 · 100問 · 1年前Module 2 Part 2
Module 2 Part 2
100問 • 1年前Module 2 (Part 2)
Module 2 (Part 2)
ユーザ名非公開 · 100問 · 1年前Module 2 (Part 2)
Module 2 (Part 2)
100問 • 1年前Module 2 Part 3
Module 2 Part 3
ユーザ名非公開 · 85問 · 1年前Module 2 Part 3
Module 2 Part 3
85問 • 1年前Module 4
Module 4
ユーザ名非公開 · 100問 · 1年前Module 4
Module 4
100問 • 1年前Module 4 Part 2
Module 4 Part 2
ユーザ名非公開 · 100問 · 1年前Module 4 Part 2
Module 4 Part 2
100問 • 1年前Module 4 Part 3
Module 4 Part 3
ユーザ名非公開 · 60問 · 1年前Module 4 Part 3
Module 4 Part 3
60問 • 1年前Module 2 (Part 4)
Module 2 (Part 4)
ユーザ名非公開 · 68問 · 1年前Module 2 (Part 4)
Module 2 (Part 4)
68問 • 1年前Randome Questions
Randome Questions
ユーザ名非公開 · 13問 · 1年前Randome Questions
Randome Questions
13問 • 1年前1
1
ユーザ名非公開 · 100問 · 1年前1
1
100問 • 1年前Module 2 (Part 5)
Module 2 (Part 5)
ユーザ名非公開 · 100問 · 1年前Module 2 (Part 5)
Module 2 (Part 5)
100問 • 1年前2
2
ユーザ名非公開 · 100問 · 1年前2
2
100問 • 1年前Module 2 (Part 6)
Module 2 (Part 6)
ユーザ名非公開 · 68問 · 1年前Module 2 (Part 6)
Module 2 (Part 6)
68問 • 1年前Module 4 Part 1
Module 4 Part 1
ユーザ名非公開 · 5問 · 1年前Module 4 Part 1
Module 4 Part 1
5問 • 1年前問題一覧
1
DDB
2
Ponstan 500 mg
3
Increased risk of GI bleeding
4
Ginseng - Amitriptyline
5
Contrast media
6
Phenylephrine
7
It blocks H1-receptors in the brain
8
N-acetylcysteine
9
Bone marrow suppression
10
I only
11
Omeprazole beads in applesauce for Edna with GERD and has problems swallowing capsules
12
Sirolimus
13
Vasopressin
14
M. ft. sol
15
If another drop of eye medication is needed, immediately instill another drop in the same area
16
Aged cheese, Moclobemide
17
Benign Prostatic Hypertrophy (BPH)
18
Atorvastatin
19
II only
20
III,IV
21
Synergism
22
II, IV
23
Type E
24
Type C: Cardiotoxicity by Doxorubicin
25
Signa
26
Precaution, Warning, Contraindication
27
Object drug
28
III and V
29
All except II and IV
30
I and III
31
No effect on the antibiotic with decreased effect of the OCP
32
I and II only
33
Category C
34
Category D
35
III and IV only
36
Pharmaceutical alternative
37
DOPamine and DOBUTamine
38
Patients must be discouraged from drinking alcohol while on metronidazole therapy
39
Leaching
40
Category H
41
I, IV, and V
42
Aspirin
43
Alkalinize the urine
44
Decrease in the absorption of the fat-soluble vitamins
45
An antimetabolite
46
S3
47
Both
48
I and III
49
Has a longer half-life
50
Hyperkalemia
51
Stage 1 hypertension
52
Prolonged muscle spasms
53
Kwashiorkor
54
Piperacillin and tazobactam exhibit pharmacodynamic potentiation
55
Increased serum concentration of Lipitor
56
Pioglitazone
57
Hypomagnesemia
58
Irreversible inactivation of H+/K+ ATPase
59
II, IV
60
Potassium
61
Vitamin B12
62
Cost Benefit Analysis
63
Cost-Utility Analysis
64
Not True
65
Category E
66
Liver function test
67
Average weight of hemoglobin contained in a red cell
68
Sildenafil
69
K Sparing Diuretic
70
Custodial Care Facility
71
Primary Care Facility
72
All except III
73
III, IV, V
74
Level 3
75
Core List
76
18
77
Troponin I
78
Administration of narcotic analgesic
79
Violative
80
III, II, V, IV, I
81
0.75
82
500
83
1.33
84
15,000
85
136.36
86
0.6
87
88.68
88
0.812 g/mL
89
3.61%
90
0.50
91
33.90%v/v
92
11.08 mL/hr
93
6 pm
94
Overdose
95
45.75 mg
96
20 mg
97
470 mg
98
2.93
99
75.26
100
3000 mOsmol/L